GemVax&KAEL Co.,Ltd (082270.KQ)

KRW 13880.0

(-2.94%)

Annual Income Statements

(In KRW)
Breakdown 2023 2022 2021 2020 2019
Revenue 72.2 Billion 75.8 Billion 60.37 Billion 65.66 Billion 42.66 Billion
Cost of Revenue 46.16 Billion 53.94 Billion 41.48 Billion 40.11 Billion 28.12 Billion
Gross Profit 26.04 Billion 21.86 Billion 18.88 Billion 25.54 Billion 14.53 Billion
Operating Expenses 33.91 Billion 25.43 Billion 21.33 Billion 24.11 Billion 106.11 Billion
Selling, General and Administrative Expenses 5.16 Billion 3.72 Billion 4.59 Billion 3.95 Billion 15.52 Billion
Research and Development Expenses 15.67 Billion 11.63 Billion 7.24 Billion 4.5 Billion 4.94 Billion
Other Expenses 13.07 Billion 53.51 Million -673.57 Million -989.38 Million -
Cost and Expenses 80.07 Billion 79.37 Billion 62.82 Billion 64.22 Billion 134.24 Billion
Operating Income -7.86 Billion -3.94 Billion -3.62 Billion 1.43 Billion -7.57 Billion
Interest Expense 462.85 Million 445.31 Million 404.95 Million 1.22 Billion 3.21 Billion
Income Tax Expense -170.86 Million -5.31 Billion 14.01 Billion 9.64 Billion -
Earnings before Tax -27.34 Billion -19.6 Billion 12.05 Billion 1.63 Billion -94.78 Billion
Net Income -27.17 Billion -19.6 Billion 12.05 Billion 1.63 Billion -94.78 Billion
Earnings Per Share Basic -691.00 -497.00 304.00 42.00 -2636.00
Earnings Per Share Diluted -690.62 -515.00 280.00 -162.00 -2636.00
Weighted Average Shares Outstanding 39.32 Million 39.44 Million 39.66 Million 38.92 Million 35.95 Million
Weighted Average Shares Outstanding (Diluted) 39.35 Million 38.06 Million 39.86 Million 39.66 Million 35.95 Million
Gross Margin 0.36 0.29 0.31 0.39 0.34
EBIT Margin -0.20 -0.08 0.21 0.19 -0.14
Profit Margin -0.38 -0.26 0.20 0.02 -2.22
EBITDA -14.27 Billion -6.21 Billion -135.44 Million 1.67 Billion -5.89 Billion
Earnings Before Tax Margin -0.11 -0.05 -0.06 0.02 -0.18

Income Statement Charts